Evidence map›Paper›PMID 41258716›Full record

ArticlemSphere2025

From description to implementation: key takeaways from the 3rd African Microbiome Symposium.

Charissa C Marsh, Kristien Nel Van Zyl, Olubukola Oluranti Babalola, Reinhard Böhmer, Don A Cowan, Kgabo L M Moganedi, Itumeleng Moroenyane, Jerolen Naidoo, Abigail Nieves Delgado, Joram M Posma and 2 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Charissa C Marsh *African Microbiome Institute, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Kristien Nel Van Zyl *African Microbiome Institute, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0001-5529-4526
Olubukola Oluranti BabalolaFood Security and Safety Focus Area, Faculty of Natural and Agricultural Sciences, North-West University, Mmabatho, South Africa.ORCID 0000-0003-4344-1909
Reinhard BöhmerPathCare laboratories, Cape Town, South Africa.
Don A CowanCentre for Microbial Ecology and Genomics, Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria, South Africa.
Kgabo L M MoganediDepartment of Biochemistry, Microbiology and Biotechnology, University of Limpopo, Sovenga, South Africa.
Itumeleng MoroenyaneThe Plant Holobiont Lab, Department of Botany and Zoology, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.
Jerolen NaidooCouncil for Scientific and Industrial Research, Future Production Chemicals Cluster, Pretoria, South Africa.
Abigail Nieves DelgadoFreudenthal Institute, Utrecht University, Utrecht, the Netherlands.
Joram M PosmaSection of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom.ORCID 0000-0002-4971-9003
Leopoldo N SegalDivision of Pulmonary, Critical Care, and Sleep Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Mathabatha E SetatiAfrican Microbiome Institute, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-5450-009X

Funding

Longitudinal microbiome-host interactions and clinical outcomes in drug-resistant tuberculosis patientsK43TW012302 · FIC · STELLENBOSCH UNIVERSITY · PI Charissa Camille Naidoo · 2022 to 2026
$447k
FIC NIH HHS K43 TW012302National Research Foundation KIC240402211772NIH HHS K43TW012302
6 · The paper itself

Abstract

The 3rd African Microbiome Symposium was held in Cape Town, South Africa, from 20 to 22 November 2024. The symposium featured a diverse range of local and international microbiome research and provided a platform for 79 researchers, students, and industry members to engage in discussions on the microbiome within an African context and focusing on translational research. This meeting review shares highlights, findings, and recommendations derived from the event. Insights from two panel discussions revealed key barriers to microbiome research in Africa, including limited funding, infrastructure gaps, and a shortage of trained local scientists. Recommendations centered on increased investment, institutional training, adherence to ethical guidelines, and the fostering of equitable global partnerships.

Indexed as

MicrobiotaAfricaBiomedical ResearchHumansSouth AfricaTranslational Research, Biomedicalafrican microbiomescapacity buildingmetagenomicstranslational research

Identifiers

PMID41258716
PMCPMC12724225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.